InvestorsHub Logo

DaubersUP

01/03/19 9:11 PM

#253364 RE: Lemoncat #253363

Good stuff indeed. As time passes I would not be surprised to see that MEGA B deal. Huge cash upfront with major milestones for every current indication and some additional incentives for hooking up on future findings. It won’t be long because we all know ipix needs cash and the question will be....who is the lucky suitor who steps up.

Great article today. I told Leo to invest Dr Ms salary to hiring some PR. Every new eye with factual info is good. This was a good article

steelyeye

01/03/19 9:43 PM

#253365 RE: Lemoncat #253363

This post should be stickied for done deals by which to compare against IPIX successes and stages of IPIX compounds.




Sometimes it helps to looks at some of the good deals that took place on pipeline assets at similar stages to Brilacidin (two indications ready for phase 3, multiple preparing for phase 2)

https://www.formatherapeutics.com/wp-content/uploads/2017/11/Top_10_Hit_Parade_EndPoints_NOV2017_2.pdf

Some real whoppers in there and we're very competitive to some of the assets scooped up there.

It's also nice to see some preclinical deal numbers:

https://ceoworld.biz/2017/12/05/a-review-of-preclinical-deals-in-2017/

It clearly highlights how a phase 2 (or even phase 1) is not necessary to sign a deal much greater than our current market cap.

scottsmith

07/22/19 5:32 PM

#268264 RE: Lemoncat #253363

Unfortunately this sticky post turned out to be very misleading as the deal comps were not remotely close to the lackluster partnership deal for UP.